Amcor (AMCR)
NYSEMaterialsPackaging & ContainersSnapshot 2026-09-14
$42.25-0.17%
Close 2026-09-14 · 1-day change
NYSEMaterialsPackaging & ContainersSnapshot 2026-09-14
Research Workspace
Put AMCR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Generate free cash flow of $1.8-$1.9 billion in fiscal 2026: FCF $1.55B vs $1.8B target.
View ThesisRevenue growth is accelerating — up about 57% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 36%, softest on share dilution.
View QualityManagement screens strong on earnings delivery, margins, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAmcor's growth depends on achieving $260 million in synergy benefits in fiscal 2026. Revenue grew 77% year over year, and the last quarter beat expectations. It trades at 13× P/E versus a peer median of 18×. This suggests the price reflects less growth than expected. The primary risk is failing to generate $1.8-$1.9 billion in free cash flow. Peer multiples imply a price about 21% above where it trades. This read is provisional.
Trailing returns as of 2026-09-14. AMCR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 14 analysts currently covering AMCR (as of Sep 2026).
Based on 5 Wall Street analysts offering 12-month price targets for AMCR in the last 4 months.
Continue this research
Compare AMCR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AMCR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Paper & Plastic Packaging Products & Materials — fair value, gap to price, and forward P/E.
Compare the value case
Put AMCR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Deliver $260 million synergy benefits in fiscal 2026
Synergy gains directly support growth objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $42.25
The last 12 months of price, then the range of analyst 12-month targets from today’s $42.25.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Leadership change may impact operational execution and synergy delivery.
Advances: Deliver $260 million synergy benefits in fiscal 2026
Synergies discussed align with growth objectives.
Advances: Deliver $260 million synergy benefits in fiscal 2026
Synergy beat indicates progress towards synergy benefits.
Threatens: Achieve EPS growth of 12-17%
EPS range lower than expected, impacting growth objective.
Advances: Achieve EPS growth of 12-17%
Quarterly beat supports EPS growth objective.
Advances: Achieve EPS growth of 12-17%
Earnings beat indicates potential for EPS growth.
Threatens: Capex between $850-900 million
Flat shares indicate concerns over transition period.
